References in SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis - Clinical Therapeutics
SGLT2 inhibitor dosing chart
IJMS | Free Full-Text | Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial -
![sglt-2_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/sglt2.png "sglt-2_inhibitors [TUSOM | Pharmwiki]")
sglt-2_inhibitors [TUSOM | Pharmwiki]
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits - American Journal of Cardiology
Sodium-Glucose Cotransporter 2 Inhibitors: An Overview
Scheme representing the proposed effects of SGLT2 inhibitor on NLRP3... | Download Scientific Diagram
Is an SGLT2 inhibitor right for your patient with type 2 diabetes? | Diabetes Hub
Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review | Cardiovascular Ultrasound | Full Text
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease | Nature Communications
The role of SGLT2 inhibitors in Type 2 Diabetes | BJFM
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure | Heart
PLOS ONE: The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
More reasons to use SGLT2 inhibitors: EMPEROR-reduced and DAPA-CKD - Kidney International
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism | SpringerLink
SGLT2 Inhibitors: A New Class of Diabetes Medications
Summary of Heart Failure Outcomes in SGLT2 Inhibitor Clinical Studies | Radcliffe Cardiology
SGLT2 inhibitors: molecular design and potential differences in effect - Kidney International
Comparison of SGLT2 inhibitor and GLP-1 receptor agonist as addition metformin or metformin plus sulfonylurea: systematic review with indirect comparison meta-analysis - Virtual Meeting | EASD
SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report - Kidney Medicine
SGLT2 Inhibitors in Heart Failure: DAPA-HF & EMPEROR Trials
Black, Asian, female patients less likely to receive SGLT2 inhibitor prescription
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition - ScienceDirect
